| Molecular formula | C27H44N4O5 |
|---|
| Molecular weight | 504.7 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 129010512 |
|---|
What dihexa is
Dihexa is a synthetic small molecule identified by PubChem CID 129010512, with a molecular formula of C27H44N4O5 and a molecular weight of about 504.7 g/mol. It has not been reviewed or approved by the FDA, and no FDA label exists for it. There is no approved indication, dosage form, or verified mechanism of action associated with this compound in any regulatory record.
Regulatory and research status
Dihexa is classified as an unapproved research compound. It carries no boxed warning designation because it has no approved label at all. Any use outside of formal research settings falls outside FDA oversight.
What the evidence shows
Public clinical trial registries list zero registered studies for dihexa at this time. This means there is no clinical trial data, published trial phase, or trial status to report for this compound.
FAQ
No. Dihexa has no FDA-approved label, no approved indication, and no approved brand name. It is classified as an unapproved research compound.
Public registries currently list zero registered clinical trials for dihexa. There is no trial data, phase information, or trial status available for this compound.
Dihexa is a synthetic small molecule with the molecular formula C27H44N4O5 and a molecular weight of approximately 504.7 g/mol. It is catalogued in PubChem under CID 129010512.
No adverse event data is available for dihexa because it has no approved label and no reported cases in public adverse event databases. This means no side effect profile can be summarized at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03